TruSight™ Oncology 500 HRD at Oncopole Toulouse (France) ft. Dr. Guillaume Bataillon

25 September 2023

TruSight™ Oncology 500 HRD* is available now. Enable comprehensive genomic profiling (CGP) with accurate homologous recombination deficiency (HRD) assessment, powered by Myriad Genetics. Hear from customer Dr. Guillaume Bataillon at Oncopole Toulouse why the center chose to bring TSO 500 HRD in-house to the laboratory. *TruSight Oncology 500 not available in Japan Subscribe to the Illumina video channel A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos View Illumina webinars View Illumina product videos View Illumina support videos Facebook: LinkedIn: Instagram: Twitter: #HRD #homologousrecombinationdeficiency #CGP #comprehensivegenomicprofiling #oncology #oncologytesting #Illumina #NGS #nextgenerationsequencing #biomarkers #pathology #TruSightOncology500 #TSO500 #TSO500HRD

Share this article on